Gavriatopoulou, M., Musto, P., & Hegenbart, U. (2018). European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias. Leukemia, 32(9), . https://doi.org/10.1038/s41375-018-0209-7
Chicago Style (17th ed.) CitationGavriatopoulou, Maria, Pellegrino Musto, and Ute Hegenbart. "European Myeloma Network Recommendations on Diagnosis and Management of Patients with Rare Plasma Cell Dyscrasias." Leukemia 32, no. 9 (2018). https://doi.org/10.1038/s41375-018-0209-7.
MLA (9th ed.) CitationGavriatopoulou, Maria, et al. "European Myeloma Network Recommendations on Diagnosis and Management of Patients with Rare Plasma Cell Dyscrasias." Leukemia, vol. 32, no. 9, 2018, https://doi.org/10.1038/s41375-018-0209-7.
Warning: These citations may not always be 100% accurate.